headache from glp 1 neurologist discusses the role of GLP-1 medications in migraine and idiopathic intracranial hypertension (IIH) #migraine #headache #migrainerelief #glp1 #iih Increased Headaches With Glp-1 Meds
Description
Semaglutida acta como un agonista del receptor de GLP-1 que se une de forma selectiva al receptor de GLP-1 (el objetivo del GLP-1 humano o nativo) y lo activa
Obesity also increases the risk of cardiovascular disease, where 5 kg increases in weight in adults is associated with an 11% higher risk of death from cardiovascular disease (strokes, coronary heart disease, myocardial infarction etc)
Tirzepatide (Mounjaro, Zepbound) averages roughly 2022.5% body-weight loss versus about 15% for semaglutide (Wegovy) and 1014% for Ozempic (SURMOUNT/STEP trial data)
Soykan et al
Orvosi Hetil
